COVID-19, the Continued BC-CfE Response

Following this webinar, participants will be able to:

  1. Discuss the BC-CfE’s response regarding the COVID-19 pandemic
  2. Summarize the current COVID-19 pandemic, treatments, and immunizations
  3. Describe the BC-CfE treatment program and access to ART in view of the COVID-19 pandemic
  4. Describe the virology research and activities of the BC-CfE laboratory

This webinar will include presentations from:

Dr. Julio Montaner
Executive Director & Physician-in-Chief
BC Centre for Excellence in HIV/AIDS

Dr. Peter Phillips
Clinical Professor
Division of Infectious Diseases, University of British Columbia

Dr. Zabrina Brumme and Dr. Chanson Brumme
Laboratory Director and Assistant Director, Research Laboratories
Laboratory Program
BC Centre for Excellence in HIV/AIDS

Dr. Junine Toy, Pharm D
Senior Manager, BC Centre for Excellence in HIV/AIDS Drug Treatment Program
Clinical Pharmacy Specialist, St. Paul’s Hospital

Presentations will be followed by a discussion where participants will have the opportunity to ask questions and receive real-time responses from presenters.


Cost: Free registration.

Please register for the webinar by

clicking here.

This event will be accredited.

If you are unable to attend the live webinar it will be recorded and available for viewing on BC-CfE’s Education and Training website at: education.cfenet.ubc.ca/webinars.

For questions related to this event please contact: education@bccfe.ca


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Attendees of the BC-CfE Learning Series will be able to:
  • Summarize and describe epidemiological, behavioural, virological, and other related research relevant to the management of people living with HIV and other syndemic conditions
  • Describe and demonstrate up-to-date information regarding the care of people living with HIV and syndemic conditions (including viral hepatitis and substance use) particularly in regards to primary care, antiretroviral therapy and other treatments, and comorbid conditions
  • Review new and emerging issues in the context of the management of people living with HIV and other syndemic conditions
  • Identify both clinical and community resources to support the care of people living with HIV and syndemic conditions.
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below